Skip to main content
. 2018 Dec 6;17(2):1655–1663. doi: 10.3892/ol.2018.9804

Figure 3.

Figure 3.

Kaplan-Meier curves presenting the 3-year DFS, OS and DMFS for patients with local advanced rectal cancer receiving consolidation chemotherapy (consolidation group), compared with patients not receiving consolidation chemotherapy (control group), in combination with standard adjuvant chemotherapy. (A) The 3-year DFS was significantly higher for the consolidation group compared with the control group (P=0.036). (B) The 3-year OS for the consolidation group was not significantly different compared with the control group (P=0.250). (C) The 3-year DMFS was not significantly different between the consolidation group and the control group (P=0.100). DFS, disease-free survival; OS, overall survival; DMFS, disease metastases free survival.